Aflac (NYSE: AFL) is one of 31 public companies in the “Life & Health Insurance” industry, but how does it compare to its competitors? We will compare Aflac to similar companies based on the strength of its earnings, valuation, analyst recommendations, institutional ownership, dividends, profitability and risk.
This is a summary of recent ratings and target prices for Aflac and its competitors, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Aflac presently has a consensus target price of $75.56, suggesting a potential downside of 9.99%. As a group, “Life & Health Insurance” companies have a potential upside of 9.89%. Given Aflac’s competitors stronger consensus rating and higher possible upside, analysts plainly believe Aflac has less favorable growth aspects than its competitors.
Risk & Volatility
Aflac has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500. Comparatively, Aflac’s competitors have a beta of 1.28, meaning that their average stock price is 28% more volatile than the S&P 500.
Earnings and Valuation
This table compares Aflac and its competitors gross revenue, earnings per share and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Aflac||$22.65 billion||$4.75 billion||12.66|
|Aflac Competitors||$28.40 billion||$2.33 billion||51.29|
Aflac’s competitors have higher revenue, but lower earnings than Aflac. Aflac is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Aflac pays an annual dividend of $1.72 per share and has a dividend yield of 2.0%. Aflac pays out 25.9% of its earnings in the form of a dividend. As a group, “Life & Health Insurance” companies pay a dividend yield of 2.3% and pay out 35.9% of their earnings in the form of a dividend. Aflac has increased its dividend for 34 consecutive years.
This table compares Aflac and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Institutional and Insider Ownership
65.6% of Aflac shares are held by institutional investors. Comparatively, 68.3% of shares of all “Life & Health Insurance” companies are held by institutional investors. 3.0% of Aflac shares are held by insiders. Comparatively, 9.5% of shares of all “Life & Health Insurance” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Aflac competitors beat Aflac on 10 of the 15 factors compared.
Aflac Company Profile
Aflac Incorporated is a business holding company. The Company is involved in supplemental health and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac). The Company’s insurance business consists of two segments: Aflac Japan and Aflac U.S. The Company designs the United States insurance products to provide supplemental coverage for people having medical or primary insurance coverage. Aflac U.S. offers accident coverage on both an individual and group basis. The Company offers cancer plans, critical illness plans, and critical care and recovery plans. The Company designs the United States insurance products to provide supplemental coverage for people having medical or primary insurance coverage. Aflac U.S. offers accident coverage on both an individual and group basis. The Company offers cancer plans, critical illness plans, and critical care and recovery plans.
Receive News & Ratings for Aflac Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.